Cargando…

Relative efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation by network meta-analysis

BACKGROUND: Much direct evidence has proved that the novel oral anticoagulants (NOACs) are noninferior or superior to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation, and lead to a relevant decrease in bleeding profiles. However, no study has compared NOACs with each...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Wenbin, Guo, Hongyang, Guo, Jianping, Lin, Kun, Wang, Haijun, Zhang, Yu, Wang, Yutang, Shan, Zhaoliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Systematic Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244213/ https://www.ncbi.nlm.nih.gov/pubmed/25304034 http://dx.doi.org/10.2459/JCM.0000000000000206

Ejemplares similares

Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes
por: Parrini, Iris, et al.
Publicado: (2022)

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
por: Jang, Soo Min, et al.
Publicado: (2020)

Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: a systematic review
por: Buck, Jackie, et al.
Publicado: (2021)

Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review
por: Wilke, Thomas, et al.
Publicado: (2016)

Elderly Bleeding Risk of Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Cohort Studies
por: Lobraico-Fernandez, Jessika, et al.
Publicado: (2019)

Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation
por: Park, Jiesuck, et al.
Publicado: (2019)

Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation
por: Cavallari, Ilaria, et al.
Publicado: (2018)

Predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide level for atrial fibrillation recurrence after radiofrequency catheter ablation
por: Zhao, Qing, et al.
Publicado: (2023)

Efficacy and Safety of Direct Oral Anticoagulants for Atrial Fibrillation Across Body Mass Index Categories
por: Kaplan, Rachel M., et al.
Publicado: (2020)

Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
por: Guo, Yutao, et al.
Publicado: (2021)

Fracture risks in patients with atrial fibrillation treated with different oral anticoagulants: a meta-analysis and systematic review
por: Xie, Xiaoping, et al.
Publicado: (2022)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
por: Prídavková, Dana, et al.
Publicado: (2019)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

Efficacy and Safety of Direct Oral Anticoagulants in Elderly Patients With Atrial Fibrillation: A Network Meta-Analysis
por: Deng, Kaisheng, et al.
Publicado: (2020)

Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022)

Safety and Effectiveness of Direct Oral Anticoagulants vs. Warfarin in Patients With Atrial Fibrillation and Endoscopy-Diagnosed Peptic Ulcer
por: Wang, Chun-Li, et al.
Publicado: (2021)

Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland
por: Mueller, Tanja, et al.
Publicado: (2018)

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2020)

Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
por: Dhamane, Amol D., et al.
Publicado: (2022)

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis
por: de Souza Lima Bitar, Yasmin, et al.
Publicado: (2019)

Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and advanced kidney disease
por: Hsu, Chia-Chen, et al.
Publicado: (2023)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
por: Basu Roy, Prithvi, et al.
Publicado: (2023)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Different Renal Function Equations and Dosing of Direct Oral Anticoagulants in Atrial Fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2022)

Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
por: Yamato, Hiroshi, et al.
Publicado: (2020)

Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and High Thromboembolic Risk. A Systematic Review
por: Acanfora, Domenico, et al.
Publicado: (2019)

Efficacy and Safety of Direct Oral Anticoagulants in Patients with Diabetes and Nonvalvular Atrial Fibrillation: Meta-Analysis of Observational Studies
por: Cao, Bo, et al.
Publicado: (2021)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019)

Convenience and satisfaction in direct oral anticoagulant–treated patients with atrial fibrillation
por: Piersma‐Wichers, Margriet, et al.
Publicado: (2021)

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
por: Gjermeni, Diona, et al.
Publicado: (2023)

Liver injury from direct oral anticoagulants
por: Juneja, Deven, et al.
Publicado: (2023)

Effect of direct oral anticoagulants in patients with atrial fibrillation with mitral or aortic stenosis: A review
por: Guo, Guigao, et al.
Publicado: (2022)

Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants
por: Mull, Hillary J, et al.
Publicado: (2020)

Prevalence of Left Atrial Appendage Thrombus in Patients Anticoagulated With Direct Oral Anticoagulants: Systematic Review and Meta-analysis
por: Alqarawi, Wael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j2fm2u0vc0m0li1ck1k65oq5v9